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Polyclonal B-cell activators (PBA)  ~ are substances which directly activate Ig- 
positive cells to proliferation and antibody secretion by interacting with recep- 
tors that  are not the immunoglobulin  receptors.  Since the activation does not 
involve the variable part of the Ig receptors (1) the activation is not immunologi- 
cally specific. However this does not necessarily imply that PBA always activate 
large  populations  of B  cells.  On the  contrarY  it  has  been  demonstrated  that 
different PBA act on different small subsets of B cells and the type of response 
reflects the differentiation stage of the responding B cells (2,  3). Thus dextran 
sulfate  (DXS) stimulates  DNA synthesis to a  large extent but little  antibody 
response, contrarywise purified protein derivate of tubercle bacteria RT32 (PPD) 
activates  antibody responses but only a  low rate  of DNA synthesis,  whereas 
lipopolysaccharide  from  Escherichia  coli  055:B5  (LPS)  activates  both  DNA 
synthesis and antibody production  (2).  Other parameters  of in vitro induction 
such as the  age of the donor,  the  organ  origin  of the cells,  the genetic back- 
ground,  and the cells density requirements,  differs significantly for each PBA 
(2, 4). 
Since PBA are competent to activate B cells of any immunological specificity 
and thus to reveal the total V gene repertoire, they should also trigger resting B 
cells with receptors directed against  self provided that  such cells exist in the 
organism.  The  existence  of autoreactive  cells  was  predicted  from  the  "one 
nonspecific  signal"  hypothesis  (5)  and  was  confirmed  by direct  experiments 
(references 6 and 7, and footnote 2). 
One of the experimental  methods used to demonstrate  the PBA capacity to 
activate  self-reactive  cells  was  to  inject  mice  with  optimal  doses of LPS for 
induction of polyclonal response (6). The sera of such animals  were collected 3 
days  after  injections  and  tested  for  cytotoxic activity  against  autologus  and 
syngeneic ~Cr-labeled  spleen cells,  using rabbit serum as a  source of comple- 
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merit  (C).  There  was  consistently  a  detectable  cytotoxic  effect,  and  proper 
controls showed that cytotoxicity was most likely due to the appearance of self- 
reacting antibodies produced by nonspeciflcally  activated B  cells. 
These findings suggested that self-reactive B cells do exist in normal animals 
and thus that they are not irreversibly tolerized. If this is so it has to be expected 
that the capacity of these cells to be activated after stimulation with different 
PBA, would reflect the heterogeneity  of all the Ig-positive cells. 
In order to investigate this, we injected mice with different PBA (DXS, LPS, 
and  PPD)  and  studied  the  C-dependent  cytotoxicity  caused  by  sera  from 
injected mice against syngeneic target cells, with regard to the different param- 
eters  used  for  characterization  of B-cell  subpopulations.  The  pattern  of the 
response that we found strongly suggested that the capacity of self-reactive cells 
to release  immunoglobulins reflected  the polyclonal-activating  capacity of the 
different  PBA used and that these responses depend on the same parameters 
used  for  differentiation  of  B-cell  subpopulations.  The  implications  of these 
findings  for the understanding  of the mechanism  of B-lymphocyte  triggering 
and for self-nonself discrimination are discussed. 
Materials and Methods 
Animals and Immunizations.  A  x  5M, A/Sn, A.CA, CBA, and A  ×  C57BL mice, matched for 
age and sex,  were used throughout the experiments.  The mice were injected intraperitoneally 
(i.p.) with varying doses of PBA in a volume not exceeding 0.2 ml. in balanced salt solution (BSS). 
Mitogens.  Three different mitogens were used.  These were  LPS obtained by phenol water 
extraction according to the method of Westphal et al.  (8)  (provided from Karolinska Institutet, 
Department of Bacteriology,  Stockholm,  Sweden),  PPD  (obtained from Statens Seruminstitut, 
Copenhagen,  Denmark)  and,  DXS  (obtained from Pharmacia  Fine  Chemicals,  Ltd.,  Uppsala, 
Sweden).  When not otherwise stated the concentration of the mitogens used throughout the ex- 
periments was 150/zg/animal. 
Sera.  Mice were bled from the retro-orbital plexus usually 4 days after mitogen injections. The 
sera  were  separated  by  centrifugation  1  h  later  and  stored  in  aliquots  at  -20°C  after being 
inactivated at 56°C for 30 rain. 
Plaque Assay.  Polyclonal  antibody production  was  measured by  a  modification of Jerne's 
hemolytic plaque  assay  using the hapten 4-hydroxy-3,5-dinitrophenylacetyl  (NNP)  coupled  to 
sheep red blood cells  (SRBC).  These target cells have been shown to be suitable for detecting 
polyclonal antibody synthesis (9). 
Reconstitution  oflrradiated Animals.  Mice were irradiated with 750 rad and left for 4 h. The 
animals were then injected with 100 IU heparin and reconstituted intravenously (i.v.) with 2.5 × 
l0  s syngeneic fetal liver cells in a  vol of 0.2 ml.  of BSS.  The mice were protected by 50  ~g/ml 
tetracycline (Dumocylin) in the drinking water. 
Target Cells.  Spleen cell suspensions from mice were obtained by pressing the spleen through 
stainless screens. The resultant suspension was pipetted vigorously and the remaining cellular 
aggregates allowed to settle for 5 min. The cells remaining in the supernate were centrifugated 
and the pellet was resuspended in a solution made up by one part of BSS and eight parts of 0.82% 
NH~Cl in order to lyse the RBC in the suspension. The cells were then washed three times before 
labeling with 51Cr. 
RBC  were  obtained by bleeding the mice  from the  retro-orbital plexus  and the blood  was 
collected in tubes containing ACD solution in order to avoid clotting. The cells were washed three 
times before labeling. 
Labeling with 5~Cr.  0.1  ml of sodium chromate (sp act 10 mCi/ml) was added to  108 packed 
spleen lymphocytes in 0.25 ml of RPMI medium supplemented with penicillin, streptomycin (500 
IU/ml) (Flow Laboratories, Irvine, Scotland), and 10% fetal calf serum. When RBC were labeled 
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min.  The cells were  then washed twice  and resuspended to a  concentration  of 10Uml in  RPMI 
medium. 
Complement.  Rabbit serum, never stored for more than 1 wk, was used as source of C  (usually 
at a  1/5 dilution in BSS) after absorption according to the method of Boyse et al. (10), using a  30% 
suspension of thymus and spleen cells. 
Assay for Cytotoxicity.  50 ~l of a  cell suspension, containing 5  x  l0  s labeled target cells, was 
pipetted  into hemolysis tubes containing 50  ~l of serum from mitogen-injectod or control mice. 
Controls consisted of target  cells incubated  with  serum from untreated  syngeneic mice in  the 
presence of C and target cells treated with C or medium alone. To measure total releasable isotope 
the target cells were incubated with sodium dodecyl sulfate (SDS). The mixtures were incubated 
for 1 h  at 37°C. After two washings in BSS the cells were resuspended in 50 ~tl of rabbit C  (RC')and 
incubated for  another hour at  37°C  in  a  water  bath.  All assays were  done  in triplicate.  After 
incubation the tubes were centrifuged and the supernates and pellets counted in a gamma counter. 
The percentage of 5'Cr released was calculated as follows: 
cpm supernate -  Bg. in counter 
(cpm pellet -  cpm supernate) -  2 Bg. in counter " 
Specific lysis was calculated according to the following formula: 
% lysis exp.  -  % lysis control  ×  100. 
% maximum lysis -  % lysis control 
Results 
Induction  of Cytotoxicity Varies with the PBA Used.  In order to study the C- 
dependent cytotoxic activity against syngeneic spleen cells of sera from mice 
injected with different PBA we injected A x  5M mice with 150 ~g ofDXS, LPS, 
and PPD. The polyclonal antibody response in normal spleen cells after stimu- 
lation with these three substances is known to differ substantially. Thus PPD 
and LPS give a high antibody response, whereas DXS induces a low antibody 
response (2). Fig. 1 shows the C-dependent cytotoxic response against synge- 
neic ~lCr-labeled spleen cells of sera collected 4 days after the injection of each 
of the  three  different mitogens.  The  rabbit  sera,  used  as  C  source,  were 
absorbed, before testing, with 1/3 of  its volume of  packed target cells in order to 
decrease the spontaneous lytic activity. The pattern of the response that we 
found reflected the different polyclonal-activating  capacity of these substances 
with a  maximum isotope release caused by sera of PPD-injected mice and a 
minimum release caused by sera of DXS-treated animals. 
Strain  Dependency  of the Lytic Activity.  One  of the  parameters  used to 
differentiate B-cells subpopulations is the different activating capacity of B- 
cell mitogens for spleen cells from different strains of mice. We have tested the 
lytic activity against syngeneic spleen cells of sera from A, A  x  5M, and CBA 
mice 4 days after injection of DXS, LPS, and PPD. As can be seen in Fig. 2 all 
the sera had cytotoxic activity, but the level of activity varied from strain to 
strain. A x  5M as well as CBA are known to respond very well to LPS, whereas 
A is a  low responder. The specific lysis caused by the sera tested reflects this 
strain dependency not only to LPS, but also to PPD as well as to DXS. This is 
in accordance with previous experiments  2 in which we could not detect any 
specific lysis with sera from LPS-injected C3H/HeJ mice, which are genetically 
nonresponders to LPS, whereas the lytic activity was very high with sera from 
C3H/Tif mice which are LPS high responders. 24 
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FIG.  1.  Percent  isotope  release  from  51Cr-labeled  spleen  cells  of A  ×  5M  mice  after 
incubation for  1 h  at  37°C  with serum from syngeneic mice injected with  150  pg of BSS 
(O... D), DXS (I...  I), LPS (O--O), and PPD (I--I).  The bar represents the value of the 
spontaneous isotope release of the target cells. Student's t test was carried out between the 
groups. (0.01 P  0.05). 
DXS Pretreatment Does Not Increase A utoantibody Production after Injection 
of LPS.  It has been reported that administration of DXS to mice, resulted in 
an enhanced in vitro response to LPS when spleen cells were cultured in vitro 4 
days after in  vivo prestimulat~on  (3).  This led to the  conclusion that  DXS- 
activated cells exhibited an increased sensitivity to LPS and that the enhance- 
ment of the response caused by DXS pretreatment was due to a direct effect of 
DXS on the cells that later responded to LPS. In order to study if this enhanced 
response  also  occurred  with  our  autoantibody  response,  we  injected  A  x 
C57BL/10 mice with 100  t~g of DXS.  4 days later we administrated 150 tLg of 
LPS to the pretreated mice as well as to normal animals. Sera were collected 4 
days later and tested for C-dependent cytotoxicity against syngeneic spleen 
lymphocytes. As can be seen in Fig. 3 we did not find any enhancement of the 
lytic response using sera from DXS-pretreated mice. The failure to reproduce 
the expected synergism could be due to the  migration in  vivo of the  DXS- 
activated  cells.  To  study  this  possibility  we  tested  spleen  cells  from  LPS- 
injected mice for polyclonal antibody response in the plaque  assay.  Table I 
shows that prestimulation with DXS increased to a large extent the polyclonal 
antibody response to LPS.  This result  argues  against the  migration  of the 
DXS-activated cells as the possible cause of lack of synergism in our original 
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FIG.  2.  A/Sn, A  x  5M, and CBA mice were injected with  150 P4g of LPS  (A), PPD  (B), and 
DXS  (C).  Sera were collected 4 days later and tested for C-dependent cytotoxicity against 
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Fro.  3.  Specific lysis of syngeneic spleen cells induced by sera from A  ×  C57BL/10. mice 
injected at day 0 with 100 ~g ofBSS  (m) or DXS (I). 4 days later both groups were reinjected 
with  100  ~g of LPS or DXS. Sera were collected 4 days after the second injection. 
can be preactivated by DXS, it may exist as a subpopulation of LPS responder 
cells whose precursors are not DXS sensitive. 
Pattern  of Response  of Polyclonally  Activated  Precursor  Cells.  DXS  has 
been shown to activate precursor B cells, while PPD and LPS lack this capacity 
(3). In order to study if this pattern could be reproduced when synthesis of self- 
reactive immunoglobulins is measured, 2.5 x  10 7 fetal liver cells were injected 
into syngeneic irradiated recipients and the sera of these animals were tested 
for their capacity  to lyse  syngeneic  spleens  cells after the administration  of 
DXS,  LPS,  and  PPD.  Since  it  has  been  reported  that  radioresistent  cells 
disappear 4 days after irradiation (3), we injected the mitogens at day 6 after 
reconstitution and the sera were collected 4 days later.  We found a significant 26  SELF-REACTIVE B CELLS 
TABLE I 
DXS Prestimulation and LPS Activation 
Day 0 prestimulation  Day 4 activation  Day 8 PFC/106 cells 
BSS  BSS  75 _+ 25 
DXS  BSS  240 _  10 
BSS  LPS  2,296 _+ 145 
DXS  LPS  4,000 _  128 
The data are  presented  as the mean  +  SE of triplicate  experiments. 
DXS injected 100 ~g/animal.  LPS injected 100 ~g/animal. 
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Fio.  4.  Specific lysis caused by sera from A × C57BL/10  mice collected at different times 
after  irradiation  and reconstitution  with fetal liver cells and injection of 100 ~tg of LPS, 
PPD, and DXS. Fig. 4 A represents  the specific lysis caused by sera from normal animals 
injected with the same PBA; Fig. 4 B represents  the specific lysis caused by sera of mice 
irradiated  and reconstituted  and injected 6 days after reconstitution; in Fig. 4 C the mice 
were injected 15 days after reconstitution. 
decrease  in  the  specific  lysis  using  these  sera  as  compared with  sera  from 
normal mice injected with the same PBA. However a  certain degree of cyto- 
toxic activity was still  detectable  (Fig.  4).  To find the  cause of this  residual 
response  we tested  spleens  of reconstituted  mice for polyclonal response.  As 
can be seen in  Table II, 6 days after irradiation there was still  a  significant 
polyclonal response,  thus excluding the possibility of complete elimination of 
radioresistant cells. When the PBA were injected at day 15 after reconstitution 
and the sera collected 4 days later, we found that the cytotoxic activity against 
syngeneic spleen cells of these sera returned to normal levels. This is in perfect 
agreement with the sequential  acquisition in the PBA responsiveness in the 
differentiation process as described by other authors  (2,  11,  12). 
Involvement  of the  Histocompatibility  Antigens  in  the Lysis  of the  Target 
Cells.  We have shown that the sera of mitogens injected mice contain anti- 
bodies  directed  against  syngeneic  cells.  These  autoantibodies  are  probably 
released  from  polyclonally activated  B  cells  that  are  programmed to  react 
against  self.  It is  of interest  to  determine the  specificity of these  antibodies 
with particular attention to the possibility that they are directed against the D.  PRIMI,  L.  HAMMARSTR{)M,  C.  I.  E.  SMITH,  AND  G.  MOLLER 
TABLE  II 
Spontaneous PFC against NNP-SRBC from Spleen Cells 2 and 5 
Days after Animals Irradiation 
Animals condition 
PFC/106 spleen cells 
IgM  IgG 
Normal animals  23.7  3.9 
Day 2 after irradiation  35.0  7.2 
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Fro.  5.  C-dependent  cytotoxicity  caused  by sera from  A/Sn mice  collected  4  days after 
injection of 150 tLg of PPD. The same sera were also absorbed, before testing, on 1/3 volume 
of target cells and on the same volume of spleen cells from A.CA mice. 
major histocompatibility  antigens,  or if they  are  capable  of reacting  with a 
variety of other surface antigens of the target cells as well. 
To study this we injected A/Sn (H-2 ~) mice with 150 tLg of PPD and collected 
the sera 4 days  later.  The sera were tested in the cytotoxic assay using the 
same sera absorbed with syngeneic spleen cells as control. Before testing, some 
of the sera were also absorbed with spleen cells from the co-isogeneic strain 
A.CA (H-2J).  Fig. 5 shows that absorption of the sera with these two kinds of 
cells eliminated the cytotoxic activity of the sera to the same extent. Since the 
only difference between the strain A/Sn and  A.CA  is in the H-2  region  we 
conclude  that  the  self-reactive  immunoglobulins  produced  by  polyclonally 
activated  B  cells  are  directed  against  a  variety  of surface  antigens  on the 
target cells and that the anti-H-2  antibodies represent,  if they  exist,  such  a 
small part of the antibodies that no detectable cytotoxicity remains. Sera from 
PPD-injected mice were capable of lysing syngeneic RBC in the presence of C 
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FIG.  6.  C-dependent cytotoxic response on syngeneic RPC caused by sera from CBA mice 
injected with 150 ~g of PPD (m) or BSS (O). 
lymphatic cells, it seems unlikely that the immunoglobulins that we detected 
against the target cells were mainly directed against the H-2  system. 
Discussion 
Our  results  indicate that  the  different activating properties  of PBA  are 
detectable also when synthesis of self-reactive immunoglobulins is measured. 
DXS stimulates the production of autoantibodies to a  relatively low extent, 
whereas LPS and PPD induce a higher degree of activation of self-reactive B 
cells. We have found a higher level of specific cytotoxicity in the sera of those 
mice that, for genetic reasons, respond better to LPS compared with those that 
respond less well. We detected a diminished level of autoantibodies in the sera 
of mice that have been irradiated and reconstituted with fetal liver cells before 
injection of LPS and PPD.  However, when these PBA were injected after a 
period that allowed the injected cells to mature,  the sera  of these  animals 
recuperated the lytic activity against syngeneic cells. This suggests that PPD 
and LPS are incompetent to activate immature B cells. It was not possible for 
us to enhance the response of LPS by pretreating the mice with DXS.  How- 
ever, when measuring the polyclonal response it was found that DXS pretreat- 
ment increased the number of plaques to NNP-SRBC after LPS injection. This 
implies that all DXS-responding cells are not necessarily the precursors of the 
later LPS-responding cells. 
These findings suggest that self-reactive B cells exist in a  resting state in 
normal animals and that they can become activated by PBA to secrete their 
gene products in the same way as all B cells.  From this it follows that self- 
nonself discrimination must be carried out at the T-cell level and that toler- 
ance does not exist at the B-cell level. 
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lymphocyte triggering.  The two-signal hypothesis (13) states that the interac- 
tion between the antigen and the Ig receptors results in an irreversible state of 
immunological tolerance.  This concept predicts that when a cell programmed 
to react against a  self-antigen becomes immunologically competent it has to 
become irreversibly tolerized, because the self-antigen will provide the tolero- 
genic signal "one". The Ig-positive cells responding to PPD and LPS have been 
shown to be mature  B  cells and therefore it has to be expected that no self- 
reactive B cells would exist in this population, since these cells would all have 
met self-antigens during their differentiation pathway.  Obviously this expec- 
tation was not fulfilled by the findings.  Another consequence of the concept is 
that the tolerizing  event should depend only on the interaction  between the 
antigen  and  the  Ig  receptor.  This  should  occur  in  all  the  Ig-positive  cells 
irrespective of the genetic background. However, we have found that autoanti- 
body production is strain dependent in a  way that cannot be explained by the 
two-signal concept. 
Instead  our  findings  are  in  accordance  with  the  one  nonspecific  signal 
hypothesis (5).  This assumes that only one nonspecific signal activates B cells 
and  this  signal  is  delivered  by nonclonally  distributed  receptors  for  PBA. 
Therefore  PBA  activate  cells  of all  specificities,  including  those  directed 
against  self.  The  prevention  of the  formation  of autoantibodies  in  normal 
conditions  is  probably due  to  the  absence  of self-reactive  T  cells.  Since  all 
autologus  antigens  are  thymus  dependent,  self-recognizing  B  cells  cannot 
normally be activated,  due to the lack of cooperation between B and T  cells. 
This theory is strongly supported by the recent demonstration that tolerance to 
a hapten protein conjugate did not effect the B cells, which could be activated 
to antibody synthesis against the tolerogen by LPS (14). 
In conclusion our findings demonstrate that self-tolerance does not exist at 
the  B-cell  level  and  that  self-reactive  cells,  as  well  as  cells  of all  other 
specificities can be activated by PBA in different ways according to their activat- 
ing capacity, thus excluding that contact between Ig receptors and self-anti- 
gens causes irreversible tolerance. 
Summary 
The existence of autoreactive B cells was predicted by theoretical considera- 
tions and,  recently,  confirmed by direct experiments.  The  aim  of the present 
work was to investigate  if the capacity of self-reactive B  cells to be activated 
with different polyclonal B-cell activators  (PBA) reflects the heterogeneity of 
the response as seen in all the Ig-positive cells. 
We injected mice with dextran  sulfate,  lipopolysaccharide from Escherichia 
coli 055:B5, and purified protein derivate ofturbercle bacteria RT32 and studied 
the complement-dependent cytotoxicity against syngeneic spleen cells caused by 
the  sera from injected  mice with regard  to the  different parameters  used for 
characterization of B-cell subpopulations. It was found that the capacity of self- 
reactive B cells to secrete antibodies reflects the polyclonal-activating capacity 
of the PBA used. The implications of these findings for the understanding of the 
triggering  mechanism of B lymphocytes and for self-nonself discrimination  are 
discussed. 30  SELF-REACTIVE  B  CELLS 
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